Skip to main content

Table 27 Studies on the reproduction and developmental toxicity of PFCs (from EFSA [15] and enhanced)

From: Toxicology of perfluorinated compounds

Substance

Experimental animal

Tested dosage and time point

Effects

NOAEL LOAELa

Reference

PFOS

Rats

1, 5, and 10 mg/kg BW/day; GD 6 to 15

Body mass of the maternal animal ↓and lens abnormalities

5

10

Gortner

[291]

 

Rats

5 and 10 mg/kg BW/day; GD 6 to 15

Weight loss of the maternal animal and developmental toxic effects: birth weight ↓, inner organ abnormalities, delayed ossification, and skeletal anomalies

1

5

Wetzel [292]

 

Rats

1, 2, 3, 5, and 10 mg/kg BW/day; GD 2 to 21

Weight gain of the maternal animal ↓; serum T4 and T3 of the maternal animal ↓; at the highest dosage: body weight of the fetus ↓, cleft palate, anasarca, death rate 4 to 6 h after birth ↑; and from 2 mg/kg BW/day: postnatal growth rate, delayed opening of eyes, T4 ↓

n.r.

Lau et al. [162]; Thiobodeaux et al. [114]

 

Mice

1, 5, 10, 15, and 20 mg/kg BW/day; GD 1 to 18

Delayed opening of eyes and from 5 mg/kg BW/day: liver mass ↑

n.r.

Lau et al. [162]; Thiobodeaux et al. [114]

 

Rats

0.4, 0.8, 1, 1.2, 1.6, and 2 mg/kg BW/day; 6 weeks before mating, during gestation, and up to the fourth day of nursing

From 0.8 mg/kg BW/day: gestation time and viability of the young animals ↓

n.r.

Lübker et al. [163, 170]

 

Rats

0.1, 0.4, 1.6, and 3.2 mg/kg BW/day; 42 days before mating, during gestation, and nursing

At highest dosage: gestation time, number of implantation points, and litter size ↓; and at the second-highest dosage (F1): reduced viability, body weight of the newborn, delayed reflexes and physical development, food uptake after weaning ↓ and dosage (F2): birth weight ↓

0.1

0.4

Christian et al. [164]

 

Rabbits

0.1, 1, 2.5, and 3.75 mg/kg BW/day; GD 6 to 20

Weight gain of the maternal animal ↓;and at the second highest dosage: birth weight ↓ and delayed ossification

0.1

1

1

2.5

Case et al. [293]

 

Mice

1, 10, and 20 mg/kg BW/day; GD 0 to the end of the study

At the highest dosage (maternal animal): weight gain, feed ↓, water uptake ↑, liver mass ↑; body weight of the fetus ↓, enlargement of the neck, skeletal deformity; and newborn weak and inactive, lung atelectasis, aneurism of intracranial arteries, respiratory dysfunction to death

n.r.

Yahia et al. [294]

 

Leghorn chickens

1, 2.5, and 5 mg/kg egg; before incubation

No effect on hatching rate, spleen mass ↑, right wings shorter, frequent occurrence of brain asymmetry, immunoglobulin (IgM, IgY) ↓, plasma lysozyme activity ↑; at the highest dosage: liver mass ↑; and at the highest dosage: body weight ↑

(1 mg/kg egg to 154 ng/g in serum)

Peden-Adams et al. [175]

 

Mallard ducks and quail

10, 50, and 150 mg/kg of feed

Viability of the 14-day-old progeny↓; at the lowest dosage: slight increase in incidences of small testes (length); however, spermatogenesis and fertility were not affected

Quail, 10 mg/kg feed

Newsted et al. [177]

PFOA

Rats

1, 3, 10, and 30 mg/kg BW/day

Body weight ↓, liver and kidney mass ↑; and at the highest dosage: birth weight ↓, mortality after weaning ↑, delayed puberty

n.r.

Butenhoff et al. [125, 165]

 

Mice

1, 3, 5, 10, 20, and 40 mg/kg BW/day; during gestation

Liver enlargement; full-term gestation, viable fetuses, fetus weight, postnatal viability ↓; and growth deficit, delayed opening of eyes, accelerated sexual maturity of male progeny

n.r.

Lau et al. [161]

 

Mice

3 to 20 mg/kg BW/day

Liver mass of the maternal animal ↑; body weight gain ↓; and application during GD 7 to 17 and 10 to 17: delayed opening of eyes and growth of coat

n.r.

Wolf et al. [169]

 

Mice

5 mg/kg BW/day; GD 1 to 17, 8 to 17, and 12 to 17

Body weight of young animals ↓ and abnormal development of the nursing process to retarded growth of progeny

n.r.

White et al. [295]

 

Chickens

5, 20, 40 mg/kg egg; before incubation

Impaired hatching rate, high prevalence of splayed legs, and chicks with partial or complete loss of yellow pigment in the down

n.r.

Yanai et al. [174]

PFBS

Rats

30 to 1, 000 mg/kg

No impairment of fertility or reproduction, no developmental toxic effects aside from a slight delay in onset of puberty, and weight gain in male F1 rats of the group with the highest dosage

n.r.

Lau et al. [115]

PFHxS

Rats

n.r.

No effect on fertility, reproduction, or viability and growth of the progeny

10

York [181] cited in Lau et al. [115]

N-Et-FOSE

Rats

n.r.

Toxic effects similar to those of PFOS, still birth, and mortality in the first three days ↑; in addition, increase in the number of stillbirths and mortality in the F2 generation

n.r.

Christian et al. [164]; Lübker et al. [163] cited in Lau et al. [115]

PFBA

Mice

35, 175, and 350 mg/kg BW/day; GD 1 to 17

No adverse effects in regard to survival rate of the progeny or their postnatal growth, delayed opening of eyes, at the two highest dosages: delayed onset of puberty, and at the highest dosage: loss of complete litter

n.r.

Das et al. [180]

PFNA

Rats

1, 3, and 5 mg/kg/day; for 14 days

Cell apoptosis in the testes and imbalance between testosterone and estradiol

n.r.

Feng et al. [183]

PFDA

Mice

0.25, 0.5, 1, 2, 4, 8, and 16, 32 mg/kg BW/day; GD 10 to 13 and 0.03, 0.3, 1, 3, 6.4, and 12.8 mg/kg BW/day; GD 6 to 15

No deformities or other developmental toxic effects; the applied dosages also did not show toxic effects in the maternal animal

n.r.

Harris and Birnbaum [182]

8:2 FTOH

Rats

n.r.

Only mild effects similar to those caused by PFOA

200

Mylchreest et al. [58] cited in Lau et al. [115]

  1. GD, gestation day; n.r., not reported; upward arrow, increased; downward arrow, decreased. aNOAEL/LOAEL, not reported in milligrams per kilogram body weight per day.